Strain of hybrid cultured mammalian cells mus musculus l used for preparing monoclonal antibody to human platelet glycoproteins iib-iiia
RU1786437C
Method for determining individual sensitivity to nifedipin in cardiovascular patients
WO9107958A1
Pharmaceutical preparation-protector of myocardium under ischemia and reperfusion
RU1778183C
Strain of hybrid cultivated cells of - mus
RU1692151C
Recombinant plasmid dna encoding plasminogen activator of urokinase type, method of its construction and the strain of bacterium escherichia coli - a producer of plasminogen activator of urokinase type
SU1721089A1
Strain of hybrid cultured mammalian mus musculus l - a producer of monoclonal antibody to glutamate receptors of human brain
SU1684339A1
Strain of yeast saccharomyces cerevisiae - a producer of human interleukin-2
SU1684675A1
Method for vanilylmandelic acid determination in urine
SU1678368A1
Noncorrectable refractory arterial hypertension
SU1685405A1
Method for determining concentration-absorption dysfunction of the biliferous ducts
SU1683677A1
Method for determining individual sensitivity of exertion angina patients to nitrates and corinfar
SU1669919A1
Method for preparation of heparin derivatives with athrombogenic action
SU1704756A1
Method for diagnosing arterial hypertension
SU1671687A1
Strain of hybridous cultured mammalian cells mus musculus l - a producer of monoclonal antibody for c-terminal site a- chain of human fibrinogen
SU1631570A1
Method for simulation of occlusive-reperfusion arrhythmia
SU1602866A1
Strain of hybrid cultivable mus musculus l cells used for producing monoclonal antibodies to human collagen
SU1602867A1
Strain of hybrid cultivable mus musculus l cellis used for producing monoclonal antibodies to human collagen
WO8906134A1
Pharmaceutical preparation for treating immunodeficiency conditions
SU1599883A1
Method of modeling myocardium infarction
EP0336976A1
Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis.
